S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › 200028 › Research report
← 200028 page
XStocksXray
Market X-Ray report · 19 October 2026

China National Accord Medicines Corp Ltd (200028)

Shenzhen Stock Exchange · China · prices in HKD · close of 19 Oct 2026

Key indicators

Last closeHKD 12.07
52-week range11.31 – 12.12
Return, 1 month / 3 months−0.2% / +3.4%
Return, 1 year / 3 years+4.4% / +9.7%
TrendUptrend
RSI (14)57
Volatility (1 year)9.6%
Worst drawdown (1 year)-6.2%
Average daily value traded1.50M HKD
Dividend yield6.4%

Market X-Ray price-based

74/ 100 · High confidence · ahead of 93% of stocks on this exchange
Trend90
Momentum72
Stability (higher is calmer)99
Liquidity1
Income82

Five-year price chart navy: price · brown: 200-day average

8.399.5510.7111.8613.022021-102023-012024-042025-072026-10

Summary

China National Accord Medicines Corp Ltd (200028) trades on the Shenzhen Stock Exchange in China. It last closed at HKD 12.07 on 19 October 2026.

Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 193 of 2,821 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 4.4% and over the last three months it rose 3.4%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
China National Accord Medicines Corp Ltd (200028)

The five lenses in numbers each metric is ranked against the other stocks on Shenzhen Stock Exchange

Lens and metricValueScoreReading
Trend90 · StrongTrading above its long-term averages and near its highs.
Above 200-day average1.9%
From 52-week high-0.3%
Momentum72 · StrongRising faster than most stocks on this exchange.
3-month return3.4%
6-month return0.5%
12-month return, skipping the last month4.6%
Stability (higher is calmer)99 · StrongCalmer than most: low volatility and shallow drawdowns.
Volatility, 1 year (lower is calmer)9.6%
Worst drawdown, 1 year (smaller is calmer)-6.2%
Liquidity1 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded1.50M HKD
Zero-volume days0.0%
Income82 · StrongDividend is high and has been paid regularly.
Dividend yield6.4%
Years with dividends5

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.
  • Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
  • Income: Dividend is high and has been paid regularly.

Weak spots

  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week+0.2%
1 month−0.2%
3 months+3.4%
6 months+0.5%
1 year+4.4%
3 years+9.7%
5 years–

Signals

50-day / 200-day average11.98 / 11.85
Golden / death cross (60 days)Golden, 49 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.10

Technical summary

DailyStrongly bullish12 bullish · 1 neutral · 3 bearish
WeeklyStrongly bullish11 bullish · 1 neutral · 0 bearish
MonthlyStrongly bullish7 bullish · 1 neutral · 0 bearish

Recent dividends

Ex-dividend dateAmount per share
24 Jun 2026CNY 0.7765
25 Jun 2025CNY 0.4000
25 Jun 2024CNY 0.7482
1 Jun 2023CNY 1.1734
17 Jun 2022CNY 0.7253
21 Jun 2021CNY 0.9596

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shenzhen Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026